Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment
NCT02506686
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Central Nervous System Infections
Interventions
DRUG:
Meropenem
Sponsor
Huashan Hospital